Literature DB >> 24332482

Contributions of B cells to lupus pathogenesis.

Allison Sang1, Ying-Yi Zheng1, Laurence Morel2.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies. This review summarizes first the results obtained in the mouse that have revealed how B cell tolerance is breached in SLE. We then review the B cell subsets, in addition to the autoAb producing cells, which contribute to SLE pathogenesis, focusing on marginal zone B cells, B-1 cells and regulatory B cells. Finally, we review the interactions between B cells and other immune cells that have been implicated in SLE, such as dendritic cells, macrophages, neutrophils and T cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; B cells; Lupus

Mesh:

Substances:

Year:  2013        PMID: 24332482      PMCID: PMC4053496          DOI: 10.1016/j.molimm.2013.11.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  177 in total

Review 1.  The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation.

Authors:  L Peiser; S Gordon
Journal:  Microbes Infect       Date:  2001-02       Impact factor: 2.700

2.  Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.

Authors:  J E Wither; V Roy; L A Brennan
Journal:  Clin Immunol       Date:  2000-01       Impact factor: 3.969

3.  Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.

Authors:  D Zeng; M K Lee; J Tung; A Brendolan; S Strober
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

4.  Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.

Authors:  Y Qian; C Santiago; M Borrero; T F Tedder; S H Clarke
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

5.  Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells.

Authors:  I R Rifkin; E A Leadbetter; B C Beaudette; C Kiani; M Monestier; M J Shlomchik; A Marshak-Rothstein
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

6.  Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.

Authors:  S Santulli-Marotto; Y Qian; S Ferguson; S H Clarke
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

7.  Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains.

Authors:  L Morel; B P Croker; K R Blenman; C Mohan; G Huang; G Gilkeson; E K Wakeland
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

9.  CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.

Authors:  P Schaerli; K Willimann; A B Lang; M Lipp; P Loetscher; B Moser
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.

Authors:  D Breitfeld; L Ohl; E Kremmer; J Ellwart; F Sallusto; M Lipp; R Förster
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  30 in total

1.  Autoreactive helper T cells alleviate the need for intrinsic TLR signaling in autoreactive B cell activation.

Authors:  Josephine R Giles; Adriana Turqueti Neves; Ann Marshak-Rothstein; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-02-23

Review 2.  The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.

Authors:  Malika Hale; David J Rawlings; Shaun W Jackson
Journal:  Curr Opin Immunol       Date:  2018-11-01       Impact factor: 7.486

Review 3.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 4.  What rheumatologists need to know about innate lymphocytes.

Authors:  Mark A Exley; George C Tsokos; Kingston H G Mills; Dirk Elewaut; Ben Mulhearn
Journal:  Nat Rev Rheumatol       Date:  2016-09-02       Impact factor: 20.543

Review 5.  Metabolic Factors that Contribute to Lupus Pathogenesis.

Authors:  Wei Li; Ramya Sivakumar; Anton A Titov; Seung-Chul Choi; Laurence Morel
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

6.  Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.

Authors:  Rita Kansal; Noah Richardson; Indira Neeli; Saleem Khawaja; Damian Chamberlain; Marium Ghani; Qurat-Ul-Ain Ghani; Louisa Balazs; Sarka Beranova-Giorgianni; Francesco Giorgianni; James N Kochenderfer; Tony Marion; Lorraine M Albritton; Marko Radic
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

Review 7.  Homeostasis and regulation of autoreactive B cells.

Authors:  Sujin Lee; Yeunjung Ko; Tae Jin Kim
Journal:  Cell Mol Immunol       Date:  2020-05-07       Impact factor: 11.530

8.  Abnormal phenotypic features of IgM+B cell subsets in patients with chronic hepatitis C virus infection.

Authors:  Fanyun Kong; Bo Feng; Henghui Zhang; Huiying Rao; Jianghua Wang; Xu Cong; Lai Wei
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

Review 9.  Association between BLK polymorphisms and susceptibility to SLE : A meta-analysis.

Authors:  G G Song; Y H Lee
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

10.  B cell-intrinsic TLR9 expression is protective in murine lupus.

Authors:  Jeremy S Tilstra; Shinu John; Rachael A Gordon; Claire Leibler; Michael Kashgarian; Sheldon Bastacky; Kevin M Nickerson; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.